A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects

Clinical trial NCT01239771 · COMPLETED

Trial details

NCT number: NCT01239771
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.

Start date: 2011-01-01
Primary completion: 2011-05-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.